100+ Vendors
50+ Compounds
100+ Vendor COAs
Price/MG Comparison
Exclusive Coupons
Peptide GradingPeptide Grading

Phase I–II Clinical Trials

AOD-9604

Fat Metabolism ResearchhGH FragmentWeight Research

From

$39.99

Vendors

26

Lab tested

7 COAs

Key benefits

  • Increased fat breakdown in animal studies
  • Did not raise IGF-1 in trials, unlike full growth hormone
  • Tested in human obesity trials
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191 with an added tyrosine). It was developed to study growth hormone's effect on fat breakdown without its effects on growth or blood sugar, and reached human weight-loss trials before development stopped.

Regulatory activity

Phase I–II Clinical Trials

Early-stage human trials

Route

Subcutaneous

Often studied away from meals; timing varies by protocol.

Cycle

Varies by study

Typical duration

Storage

-20°C lyophilized · 2–8°C once reconstituted

Follow vendor guidance

Marketplace

Compare all AOD-9604 vendors

Prices per size, coupon codes, lab reports and shipping.

26 offers

What the research reports

Research Benefits of AOD-9604

What published research has reported so far. These are research findings, not promised results.

01

Increased fat breakdown in animal studies

02

Did not raise IGF-1 in trials, unlike full growth hormone

03

Tested in human obesity trials

What the evidence shows

AOD-9604 showed fat-reducing effects in obese rodents and was taken into human clinical trials for obesity. The later, larger trials did not show meaningful weight loss compared with placebo, and development as a weight-loss drug was discontinued.

Safety and regulatory position

Not approved · development discontinued

AOD-9604 is not approved as a medicine. Human trials reported it was generally well tolerated over the periods studied, but it never completed approval. Vendors sell it for laboratory research use only.

FAQ

Frequently asked questions.

AOD stands for Anti-Obesity Drug. 9604 was its development number.